Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06902714 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Feb 2026 to Apr 20, 2026 · Site details revisedv5 Show 2 more changesShow less
    • Start date changed from estimate of Feb 2026 to Apr 20, 2026
    • Site details revised
  2. Start date: Dec 15, 2025 to Feb 2026v4
  3. Start date: Sep 15, 2025 to Dec 15, 2025v3
  4. Primary completion date: Jul 2026 to Jul 2028 Start date: Jul 2025 to Sep 15, 2025 · Completion date: Dec 2026 to Dec 2030 · Site contact updatedv2 Show 3 more changesShow less
    • Start date: Jul 2025 to Sep 15, 2025
    • Completion date: Dec 2026 to Dec 2030
    • Site contact updated
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid
Trial Details
NCT Number NCT06902714
Lead Sponsor University of Alabama at Birmingham
Conditions Shoulder Arthroplasty
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov